Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders

Aims. To evaluate the prognostic value of adipokines in patients with myocardial infarction (MI) and various glucose metabolism disorders. Materials and Methods. Consecutive patients aged ?80 years and diagnosed with MI (380 patients, 63.4% males) were examined. The patients were classified into f...

Full description

Saved in:
Bibliographic Details
Main Authors: Kamila Kahramonzhonovna Kholmatova, Irina Vladimirovna Dvoryashina, Irina Adolfovna Fomkina, Tatiana Vyacheslavovna Supryadkina
Format: Article
Language:English
Published: Endocrinology Research Centre 2014-10-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/6440
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849729873922228224
author Kamila Kahramonzhonovna Kholmatova
Irina Vladimirovna Dvoryashina
Irina Adolfovna Fomkina
Tatiana Vyacheslavovna Supryadkina
author_facet Kamila Kahramonzhonovna Kholmatova
Irina Vladimirovna Dvoryashina
Irina Adolfovna Fomkina
Tatiana Vyacheslavovna Supryadkina
author_sort Kamila Kahramonzhonovna Kholmatova
collection DOAJ
description Aims. To evaluate the prognostic value of adipokines in patients with myocardial infarction (MI) and various glucose metabolism disorders. Materials and Methods. Consecutive patients aged ?80 years and diagnosed with MI (380 patients, 63.4% males) were examined. The patients were classified into four groups: I, with normal glucose tolerance; II, with prediabetes; III and IV - with newly detected and previously diagnosed type 2 diabetes mellitus, respectively. Levels of insulin, C-peptide and cortisol during glucose tolerance test and basal levels of apolipoproteins AI, B100, leptin and adiponectin were determined in 113 patients with Q MI. Cardiovascular events were analysed for the next 2 years after MI. Logistic regression analysis was used to identify the risk factors of poor prognosis after MI. Results. Elevated levels of leptin with decreased levels of adiponectin were observed in all MI patients independent of the degree of glucose metabolism disturbance. A linear trend of leptin level increase was observed starting from group I to group IV (Jonckheere?s test: J=2218.0; z=3.411; р=0.001). Multiple regression analysis showed that the basal insulin level was an independent predictor of death during the 2 years after MI (OR=0.639; р=0.033). MI prior to hospitalisation (OR=5.633; р=0.013), basal hypercortisolaemia (OR=5.435; р=0.016), glycaemia (OR=1.213; р=0.023) and heart rate (OR=1.051; р=0.032) on admission were associated with the occurrence of repeated MI. Leptin levels (OR=1.018; р=0.031) and creatine kinase-MB fraction (OR=1.009; р=0.018) were risk factors of the occurrence of the combined end-point of cardiovascular events. Conclusion. An imbalance of adipokines was observed in MI patients regardless of the presence of glucose disorders. The levels of leptin, glycaemia, insulin and basal hypercortisolaemia were significantly associated with the occurrence of cardiovascular events during the late post-infarction period.
format Article
id doaj-art-77383757516d4b40808676d1f52bd9bc
institution DOAJ
issn 2072-0351
2072-0378
language English
publishDate 2014-10-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj-art-77383757516d4b40808676d1f52bd9bc2025-08-20T03:09:03ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782014-10-01173909510.14341/DM2014390-956492Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disordersKamila Kahramonzhonovna Kholmatova0Irina Vladimirovna Dvoryashina1Irina Adolfovna Fomkina2Tatiana Vyacheslavovna Supryadkina3Northern State Medical University, ArkhangelskNorthern State Medical University, ArkhangelskNorthern State Medical University, ArkhangelskNorthern State Medical University, ArkhangelskAims. To evaluate the prognostic value of adipokines in patients with myocardial infarction (MI) and various glucose metabolism disorders. Materials and Methods. Consecutive patients aged ?80 years and diagnosed with MI (380 patients, 63.4% males) were examined. The patients were classified into four groups: I, with normal glucose tolerance; II, with prediabetes; III and IV - with newly detected and previously diagnosed type 2 diabetes mellitus, respectively. Levels of insulin, C-peptide and cortisol during glucose tolerance test and basal levels of apolipoproteins AI, B100, leptin and adiponectin were determined in 113 patients with Q MI. Cardiovascular events were analysed for the next 2 years after MI. Logistic regression analysis was used to identify the risk factors of poor prognosis after MI. Results. Elevated levels of leptin with decreased levels of adiponectin were observed in all MI patients independent of the degree of glucose metabolism disturbance. A linear trend of leptin level increase was observed starting from group I to group IV (Jonckheere?s test: J=2218.0; z=3.411; р=0.001). Multiple regression analysis showed that the basal insulin level was an independent predictor of death during the 2 years after MI (OR=0.639; р=0.033). MI prior to hospitalisation (OR=5.633; р=0.013), basal hypercortisolaemia (OR=5.435; р=0.016), glycaemia (OR=1.213; р=0.023) and heart rate (OR=1.051; р=0.032) on admission were associated with the occurrence of repeated MI. Leptin levels (OR=1.018; р=0.031) and creatine kinase-MB fraction (OR=1.009; р=0.018) were risk factors of the occurrence of the combined end-point of cardiovascular events. Conclusion. An imbalance of adipokines was observed in MI patients regardless of the presence of glucose disorders. The levels of leptin, glycaemia, insulin and basal hypercortisolaemia were significantly associated with the occurrence of cardiovascular events during the late post-infarction period.https://www.dia-endojournals.ru/jour/article/view/6440diabetes mellitusleptin adiponectinmyocardial infarctionprognosis
spellingShingle Kamila Kahramonzhonovna Kholmatova
Irina Vladimirovna Dvoryashina
Irina Adolfovna Fomkina
Tatiana Vyacheslavovna Supryadkina
Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
Сахарный диабет
diabetes mellitus
leptin adiponectin
myocardial infarction
prognosis
title Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
title_full Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
title_fullStr Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
title_full_unstemmed Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
title_short Prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
title_sort prognostic value of adipokines in patients with myocardial infarction and glucose metabolism disorders
topic diabetes mellitus
leptin adiponectin
myocardial infarction
prognosis
url https://www.dia-endojournals.ru/jour/article/view/6440
work_keys_str_mv AT kamilakahramonzhonovnakholmatova prognosticvalueofadipokinesinpatientswithmyocardialinfarctionandglucosemetabolismdisorders
AT irinavladimirovnadvoryashina prognosticvalueofadipokinesinpatientswithmyocardialinfarctionandglucosemetabolismdisorders
AT irinaadolfovnafomkina prognosticvalueofadipokinesinpatientswithmyocardialinfarctionandglucosemetabolismdisorders
AT tatianavyacheslavovnasupryadkina prognosticvalueofadipokinesinpatientswithmyocardialinfarctionandglucosemetabolismdisorders